INBS · Insider Trading
Intelligent Bio Solutions Inc. Common Stock
Every open-market purchase and sale reported by INBS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-20 | Steven Constantine Boyages | Director | A | +5,000 | — |
| 2026-03-20 | Jason Isenberg | Director | A | +5,000 | — |
| 2026-03-20 | Spiro Kevin Sakiris | Chief Financial Officer | A | +30,500 | — |
| 2026-03-20 | Jonathan Scott Hurd | Director | A | +5,000 | — |
| 2026-03-20 | Nicola Marion Fraser | Director | A | +5,000 | — |
| 2026-03-20 | Harry Simeonidis | Chief Executive Officer | A | +30,500 | — |
| 2025-03-31 | Spiro Kevin Sakiris | Chief Financial Officer | A | +34,500 | — |
| 2024-09-27 | Harry Simeonidis | Chief Executive Officer | A | +40,000 | — |
| 2024-09-27 | Spiro Kevin Sakiris | Chief Financial Officer | A | +34,500 | — |
| 2024-03-21 | Spiro Kevin Sakiris | Chief Financial Officer | X | +9,394 | — |
| 2023-10-10 | Spiro Kevin Sakiris | Chief Financial Officer | — | — | — |
| 2023-10-06 | Spiro Kevin Sakiris | Chief Financial Officer | Buy | +112,727 | — |
| 2023-10-06 | Christopher Towers | Director | Buy | +9,090 | — |
| 2023-09-05 | Harry Simeonidis | CEO | Buy | +150 | +$284 |
| 2023-07-11 | Spiro Kevin Sakiris | Chief Financial Officer | C | +2,399 | +$13.91K |
| 2022-12-23 | Spiro Kevin Sakiris | Chief Financial Officer | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Spiro Kevin Sakiris | Chief Financial Officer | 35,892 | $57.07K |
| Harry Simeonidis | Chief Executive Officer | 34,540 | $54.92K |
| Steven Constantine Boyages | Director | 5,031 | $8.00K |
| Jonathan Scott Hurd | Director | 5,006 | $7.96K |
| Jason Isenberg | Director | 5,000 | $7.95K |
| Nicola Marion Fraser | Director | 5,000 | $7.95K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the INBS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.